Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Precision Drilling
PDS
Lantheus
LNTH
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
(FY)Feb 1, 2025 | (Q4)Feb 1, 2025 | (Q3)Nov 2, 2024 | (Q2)Aug 3, 2024 | (Q1)May 4, 2024 | (FY)Feb 3, 2024 | (Q4)Feb 3, 2024 | (Q3)Oct 28, 2023 | (Q2)Jul 29, 2023 | (Q1)Apr 29, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 0.97%6.12B | -3.43%2.7B | -10.67%1.05B | 21.48%1.63B | -1.07%737M | 48.31%6.06B | -7.44%2.8B | 11.21%1.17B | 109.53%1.34B | 217.51%745M |
Net income from continuing operations | 8.72%4.86B | -0.36%1.4B | 8.90%1.3B | 11.12%1.1B | 20.09%1.07B | 27.90%4.47B | 35.16%1.4B | 12.04%1.19B | 22.10%989M | 51.79%891M |
Operating gains losses | ---- | ---- | -96.00%1M | -105.88%-1M | -25.00%3M | 165.22%61M | -6.25%15M | 1,150.00%25M | 1,600.00%17M | 0.00%4M |
Depreciation and amortization | 14.52%1.1B | 22.62%309M | 8.57%266M | 12.77%265M | 13.79%264M | 8.68%964M | 9.09%252M | 12.39%245M | 7.80%235M | 5.45%232M |
Deferred tax | 500.00%28M | -50.00%-30M | 600.00%15M | --19M | 50.00%24M | -110.94%-7M | -168.97%-20M | -133.33%-3M | --0 | 33.33%16M |
Other non cash items | -114.29%-90M | 10.00%-9M | 57.14%-12M | -94.44%-35M | -342.86%-34M | -145.16%-42M | -110.00%-10M | -660.00%-28M | -181.82%-18M | 141.18%14M |
Change In working capital | -93.96%27M | -11.40%987M | -87.46%-568M | 187.80%236M | -40.81%-628M | 154.45%447M | -29.67%1.11B | -7.83%-303M | 117.98%82M | 73.26%-446M |
-Change in receivables | -169.07%-67M | -45.13%62M | -1,085.71%-83M | 50.00%-30M | -131.37%-16M | 273.21%97M | 175.61%113M | 86.27%-7M | -46.34%-60M | 1,120.00%51M |
-Change in inventory | -271.72%-539M | -21.28%1.88B | -6.08%-1.9B | -123.64%-246M | 57.37%-266M | -350.00%-145M | -8.45%2.38B | -34.08%-1.79B | 9.84%-110M | 42.49%-624M |
-Change in prepaid assets | ---- | ---- | -142.86%-6M | 84.21%-3M | -26.67%-19M | 45.21%-40M | -1,900.00%-20M | 163.64%14M | -11.76%-19M | 54.55%-15M |
-Change in payables and accrued expense | 16.64%645M | 23.25%-974M | 0.78%1.42B | 93.33%522M | -325.87%-323M | 173.83%553M | -20.17%-1.27B | 24.25%1.41B | 194.41%270M | 126.43%143M |
-Change in other current liabilities | 33.33%-12M | 94.62%-5M | -94.67%4M | -800.00%-7M | -300.00%-4M | -1,700.00%-18M | -3,000.00%-93M | 1,975.00%75M | -90.00%1M | 75.00%-1M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 0.97%6.12B | -3.43%2.7B | -10.67%1.05B | 21.48%1.63B | -1.07%737M | 48.31%6.06B | -7.44%2.8B | 11.21%1.17B | 109.53%1.34B | 217.51%745M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -44.26%-2.48B | -99.54%-870M | -33.55%-617M | -23.19%-563M | -17.96%-427M | -16.80%-1.72B | -21.11%-436M | -13.51%-462M | -20.58%-457M | -11.73%-362M |
Net PPE purchase and sale | -11.38%-1.92B | -16.29%-514M | 8.26%-422M | -22.66%-563M | -16.07%-419M | -18.19%-1.72B | -23.81%-442M | -13.02%-460M | -21.11%-459M | -14.97%-361M |
Net business purchase and sale | ---551M | ---359M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment purchase and sale | -260.00%-8M | -50.00%3M | -50.00%-3M | --0 | -700.00%-8M | 138.46%5M | 300.00%6M | ---2M | --2M | 90.00%-1M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -44.26%-2.48B | -99.54%-870M | -33.55%-617M | -23.19%-563M | -17.96%-427M | -16.80%-1.72B | -21.11%-436M | -13.51%-462M | -20.58%-457M | -11.73%-362M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 8.94%-3.84B | -6.02%-1.16B | -5.42%-953M | 35.95%-882M | -0.36%-840M | -27.50%-4.22B | -85.62%-1.1B | -17.40%-904M | -35.80%-1.38B | 10.10%-837M |
Net issuance payments of debt | --0 | --0 | --0 | ---- | ---- | ---500M | --0 | --0 | ---- | ---- |
Net common stock issuance | 2.36%-2.15B | -3.50%-740M | -1.15%-530M | 7.66%-458M | 9.70%-419M | -13.70%-2.2B | -187.15%-715M | -22.43%-524M | 25.75%-496M | 21.22%-464M |
Cash dividends paid | -11.05%-1.65B | -11.35%-422M | -11.32%-423M | -10.73%-423M | -10.79%-380M | -10.83%-1.48B | -11.14%-379M | -10.79%-380M | -10.40%-382M | -11.00%-343M |
Net other financing activities | -34.38%-43M | 66.67%-1M | --0 | -200.00%-1M | -36.67%-41M | 3.03%-32M | -200.00%-3M | --0 | --1M | 9.09%-30M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 8.94%-3.84B | -6.02%-1.16B | -5.42%-953M | 35.95%-882M | -0.36%-840M | -27.50%-4.22B | -85.62%-1.1B | -17.40%-904M | -35.80%-1.38B | 10.10%-837M |
Net cash flow | ||||||||||
Beginning cash position | 2.25%5.6B | 9.98%4.72B | 15.38%5.25B | 0.68%5.06B | 2.25%5.6B | -12.04%5.48B | 27.49%4.29B | 28.86%4.55B | 17.00%5.03B | -12.04%5.48B |
Current changes in cash | -259.20%-199M | -47.04%671M | -168.72%-524M | 137.32%184M | -16.74%-530M | 118.06%125M | -38.91%1.27B | -57.26%-195M | 34.53%-493M | 75.97%-454M |
Effect of exchange rate changes | -3,200.00%-66M | -225.58%-54M | 87.69%-8M | -61.11%7M | -650.00%-11M | 96.55%-2M | 13.16%43M | -54.76%-65M | 263.64%18M | 104.65%2M |
End cash Position | -4.73%5.34B | -4.73%5.34B | 9.98%4.72B | 15.38%5.25B | 0.68%5.06B | 2.25%5.6B | 2.25%5.6B | 27.49%4.29B | 28.86%4.55B | 17.00%5.03B |
Free cash flow | -3.16%4.2B | -7.12%2.19B | -12.24%624M | 20.86%1.07B | -17.19%318M | 65.02%4.34B | -11.62%2.36B | 10.06%711M | 237.93%882M | 140.51%384M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |